Stock & Company Details
Emergent Biosolutions Inc $EBS
Price:
46,691,331
52M
$432M
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
-1.29
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Technology
EBS technical indicators
Latest Emergent Biosolutions Inc (EBS) technical indicators as of 2026-06-30: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
51.43 2.3%
MACD:
-0.03 35.3%
SMA 50:
$8.37 0.1%
SMA 200:
$9.72 0.0%
EMA 20:
$8.26 0.1%
Bollinger Bands:
8.62 / 7.72
Stochastic:
88.52 15.9%
ADX 14:
19.46 2.2%
ATR 14:
0.44 2.4%
CCI 20:
86.00 17.2%
OBV:
244.11M 0.3%
ROC 12:
-0.12% 104.5%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company has four main units: vaccines, which produces specialty vaccines for public health threats; devices, such as nasal sprays, skin lotions, and injections; therapeutics, which includes antibody-based treatments; and contract development and manufacturing, which brings treatments to market through collaboration with the pharmaceutical and biotechnology industries and the United States government. Most revenue comes from U.S. government purchases of vaccines, devices, and therapeutic products. The company operates in two reportable segments; the Products Segment and the Services Segment.
Finance Bot
Ask your questions
Start by typing a question below.
